Further investigation into SGLT2is, including clarification of the mechanisms underlying their suppressive effects on tumor progression, is required to determine the biological significance of SGLT2 and its inhibitor in ccRCC. Here, SLC5A2 is linked to nonpapillary renal cell carcinoma.